Plasmid in Medical Technology
Navigation Links
Plasmid in Medical Technology
Senesco Chooses VGXI to Produce Factor 5A Plasmid
... Inc. (The Woodlands, TX) ("VGXI") to supply the plasmid portion of the Company's combination therapy ... in vivo results using its combination siRNA and plasmid against subcutaneous multiple myeloma tumors in immunodeficient mice. The Factor 5A plasmid being produced by VGXI, as Senesco's preclinical ...Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
... effective dose, head-to-head comparison against plasmid DNA vaccine, Vaxfectin(R) formulation ... includes delivery of linear DNA as well as plasmid DNA. Currently plasmid DNA vaccines, which are under development ...Genetic Immunity to Present at 2008 BIO International Convention
... the DermaVir Patch, which includes HIV-specific plasmid DNA encoded antigens. About Genetic ... technology that includes disease-specific plasmid DNA encoded antigens. DermaPrep is the ... together make up the DermaVir Patch. The plasmid DNA within DermaVir Patch's ...Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
... responses through Day 182. Vical's monovalent vaccine contained a plasmid (a closed loop of DNA) encoding the hemagglutinin (HA) surface protein ... responses against H5 as well. Vical's trivalent vaccine contains the H5 plasmid plus separate plasmids encoding consensus sequences of two highly ...Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
... faster development and production. Vical's monovalent vaccine contains a plasmid (a closed loop of DNA) encoding the hemagglutinin (HA) surface protein ... responses against H5 as well. Vical's trivalent vaccine contains the H5 plasmid plus separate plasmids encoding consensus sequences of two highly ...... is a patented nanoformulation technology that includes disease-specific plasmid DNA encoded antigens. DermaPrep is the topical administration device that ... of diseases. These two components together make up the DermaVir Patch. The plasmid DNA within DermaVir Patch's NanoComp nanoparticles is specific to HIV and ...
... time with either 0.1, 0.4 or 0.8 mg of multiple HIV antigens encoding plasmid DNA, the active substance in DermaVir Patch. The same antiretroviral ... is an antigen composition platform that combines a disease-specific plasmid DNA with the Company's formulation technology. The unique DNA for the ...
Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results
... results from a series of HIV vaccine Phase 2a clinical trials, using a plasmid DNA (pDNA) vaccine developed by the NIH Vaccine Research Center and ... vaccine trials contribute to the growing body of knowledge demonstrating plasmid DNA priming as a key factor in achieving significant immune responses ...... of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer vaccine. The candidate vaccine is based on Vical's DNA gene delivery technology and encodes human telomerase reverse transcriptase ...
... The two vaccine components differ in how the genes are packaged. The DNA prime vaccine component contains only the specific gene sequences in a plasmid DNA ring, and cannot reconstitute into an infectious virus. The HIV DNA vaccine was developed by the SMI and the Karolinska Institutet in Sweden. The ...
... blind Phase 2 clinical trial (SB-509-601) available in the fourth quarter of this year." About SB-509 SB-509 is an injectable formulation of a plasmid encoding a zinc finger DNA-binding protein transcription factor (ZFP TF(TM)) designed to upregulate the expression of the gene encoding vascular ...
... Health (NIH), an agency of the U.S. Department of Health and Human Services. The grant will fund the ongoing development of Vical's immunotherapeutic plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2), a sexually transmitted virus which is the leading cause of genital herpes. The HSV-2 ...
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
... moderate diabetic neuropathy over a six month period after a single administration of SB-509. SB-509 is an injectable formulation of plasmid DNA that encodes a zinc finger DNA-binding protein transcription factor (ZFP TF(TM)), designed to upregulate the vascular endothelial ...Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
... delivery technology. Assuming successful completion of the trial, called TAMARIS, sanofi-aventis expects to file for marketing approval in 2010. The plasmid DNA (pDNA) therapy encodes Fibroblast Growth Factor 1 (FGF-1), a growth factor that stimulates the growth of blood vessels, and is intended to reduce ...Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
... Incorporated (Nasdaq: VICL ) today announced the enrollment of the first subject in its Phase 1 trial of the company's Vaxfectin(TM)-formulated plasmid DNA (pDNA) pandemic influenza vaccine. The double-blind, placebo-controlled trial will evaluate safety, tolerability and immune responses in up to 60 ...Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
... technology. The paper, titled "Effect of plasmid DNA vaccine design and in vivo electroporation on ... this promise, vaccination using DNA plasmid alone without enhanced delivery has not been ... immune response by orders of magnitude over DNA plasmid alone. Plasmid-based vaccines induced higher ...... fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, ... facilitate delivery and expression of these plasmid DNA-based immunotherapeutics and have been shown ... enhance antibody and T-cell immune responses over plasmid DNA delivered by other methods, suggesting the ...
... for intratumoral delivery into melanoma tumors of plasmid DNA (pDNA) encoding interleukin-2 (IL-2). The ... to facilitate cellular uptake) of a plasmid DNA designed to produce IL-2 in the body. The ... fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, ...
... to clinical benefit in the patients treated with higher dosages. IL-12 plasmid was detectable in peritoneal fluid of all evaluable patients and in blood ... of only a few patients at considerably lower level, suggesting that the plasmid delivery following EGEN-001 administration was localized at the delivery ...
Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
... bacterial fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, production of the desired ... studies to boost the immune response by orders of magnitude over DNA plasmid alone. Breast cancer, prostate cancer, melanoma, HIV and hepatitis C virus ...Inovio: DNA delivery technology shows positive human results
... bacterial fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, production of the desired ... boost antibody and T-cell immune response by orders of magnitude over DNA plasmid alone, suggesting the potential to provide better protection from complex ...CytoGenix to Present at 2007 International DNA Vaccines Conference in Spain
... comparable to, and in some cases more effective than responses mediated by plasmid DNA. Data will also be shown demonstrating the effectiveness of a ... challenge experiments demonstrated that synDNA(TM) is just as effective as plasmid in mediating a protective immune response when the host is attacked ...... bacterial fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, production of the desired ... boost antibody and T-cell immune response by orders of magnitude over DNA plasmid alone, suggesting the potential to provide better protection from complex ...
... and neuroprotective properties in several models that assess nerve integrity and health. In addition, Sangamo is currently developing SB-509, a plasmid formulation of this same ZFP TF, for the treatment of diabetic neuropathy and has two ongoing Phase 2 trials in this area. Dr. Fehlings and his ...
... of clinical development with our two ongoing Phase 2 clinical trials." About the SB-509 Clinical Program SB-509 is an injectable formulation of plasmid DNA that encodes a ZFP TF, designed to upregulate the VEGF-A gene. Phase 1 Phase 1b study to assess the safety and clinical effects of a single ...
Other ContentsphylogeneticsphylogeneticsphylogenyphylogenyphylogenytreetreetreetreetreetreephylogeneticphylogeneticphylogeneticphylogeneticpigmentpigmentpigmentpigmentpigmentmembranemembranemembranemembranemembranemembranemembranemembranemembranephysiologyphysiologyphysiologyphysiologyphysiologyphysiologyphysiologyplasmidplasmidplasmidplasmidplasmidplasmidplasmidplasmidOther TagsRothRothRothOther Tagsbans 2looming 2joined 2joined 3joined 4joined 5joined 6joined 7joined 8joined 9joined 10dates 2dates 3receive 2receive 3receive 4receive 5receive 6receive 7receive 8receive 9receive 10professionals 2were 2were 3were 4were 5were 6were 7were 8were 9were 10centers 2centers 3centers 4centers 5centers 6centers 7
(Date:11/23/2009)...nity-associated strain of the deadly superbug MRSA...mmon antibioticsposes a far greater health threat ...ospitals, according to a study in the December iss... threat is easily picked up in fitness centers, sc...he overall burden of MRSA within hospitals, the re...
(Date:11/23/2009)...fe Conservation Society says that western lowland ...f Congopart of the "mother lode" of more than 125,...easingly threatened by growing humans activity in ... the swamp forests adjacent to the southwest borde... confirmed that high densities of the great apes s...
(Date:11/23/2009)...udy provides "incontrovertible evidence" that the ...umatra about 73,000 years ago deforested much of c... researchers report. , The volcano ejected an es...phere, leaving a crater (now the world,s largest v...ilometers wide. Ash from the event has been found ...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2CDC Finds U S 30th in Infant Mortality 60610 1CDC Finds U S 30th in Infant Mortality 60610 2CDC Finds U S 30th in Infant Mortality 60610 3Statins May Worsen Fatigue in Heart Failure Patients 60606 1Statins May Worsen Fatigue in Heart Failure Patients 60606 2Statins May Worsen Fatigue in Heart Failure Patients 60606 3Sun or shade 3A Pecan leaves photosynthetic light response evaluated 10611 1Sun or shade 3A Pecan leaves photosynthetic light response evaluated 10611 2(Date:11/25/2009)...ttleImprovementShownforthe4thStraightYear ,, ...LungCancerAlliance-Georgia(LCA-GA)issuedthe 4thAnn...tofprogressbeingmadeagainstthislethaldiseaseinthes...(LCA),theonlynationalorganizationdedicatedexclusiv...ratriskforlungcancer. ,, (Logo: http://www.news...
(Date:11/25/2009)...d to treat colorectal cancer also can reverse a ra...-line therapy for the disease, researchers at Vand... , Mntrier,s disease causes thickening of the sto...iting, as well as anemia and swelling in the feet ...creased risk for gastric cancer. Previously, the o...
(Date:11/25/2009)...ks placed under the skin kill tumor cells, study f...ews) -- A cancer vaccine delivered in a fingernail...a new study reports. , The method uses polymer ...d with tumor-specific antigens and implanted under... tumors. The Harvard University scientists who dev...
(Date:11/25/2009)... Nationwide Imaging Services, known a...ns for diagnostic imaging equipment, now offering ...ng financing options, service and installation wit...edical Technologies of California) , ... Nationwide Imaging Services is proud to announce ...
(Date:11/25/2009)... BioSpace.com, the premier resource f...the third edition of the BioForest™ Hotbed C...nglewood, CO (Vocus) November 25, 2009 -- BioSpace...s and information, unveiled the third edition of t... , , , ,This regional campaign is a promotional e...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2[0] Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer[1] Vanderbilt scientists report first effective medical therapy for rare stomach disorder[2] Implantable Cancer Vaccine Shows Promise[0] Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) [1] BioSpace Showcases Leading Life-Science Companies in the Northwest
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |